Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.98 USD | -17.31% | -19.04% | -41.33% |
May. 23 | Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating | MT |
May. 23 | Sector Update: Health Care Stocks Flat to Lower Premarket Thursday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.33% | 6.21B | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Transcript : Cytokinetics, Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09